Hysterectomy with sentinel lymph node dissection in the setting of preoperative endometrial intraepithelial neoplasia and an endometrial stripe ≥20 mm: a cost-effectiveness analysis

被引:0
|
作者
Bell, Sarah [1 ]
Smith, Kenneth [2 ]
Kim, Haeyon [3 ]
Orellana, Taylor [4 ]
Harinath, Lakshmi [5 ]
Rush, Shannon [1 ]
Olawaiye, Alexander [1 ]
Lesnock, Jamie [1 ]
机构
[1] Magee Womens Hosp UPMC, Gynecol Oncol, Pittsburgh, PA USA
[2] Univ Pittsburgh, Med Ctr, Gen Internal Med, Pittsburgh, PA USA
[3] Univ Pittsburgh, Med Ctr, Radiat Oncol, Pittsburgh, PA USA
[4] Med Univ South Carolina, Gynecol Oncol, Charleston, SC USA
[5] Univ Pittsburgh, Med Ctr, Pathol, Pittsburgh, PA USA
关键词
Endometrial Hyperplasia; Sentinel Lymph Node; SELECTIVE LYMPHADENECTOMY; CANCER; HYPERPLASIA; DIAGNOSIS; BIOPSY; ADENOCARCINOMA; CHEMOTHERAPY; CARCINOMA; SURGERY;
D O I
10.1136/ijgc-2024-005658
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Objectives Routine lymph node assessment in patients with endometrial intraepithelial neoplasia is institution and surgeon-dependent without clear guidelines. We sought to determine if routine sentinel lymph node (SLN) dissection at the time of laparoscopic hysterectomy for patients with a preoperative diagnosis of endometrial intraepithelial neoplasia and a preoperative ultrasound with endometrial stripe >= 20 mm is cost-effective. Methods A decision model was created to perform two cost-effectiveness analyses: (1) hysterectomy with frozen section versus hysterectomy with SLN dissection in patients with a preoperative diagnosis of endometrial intraepithelial neoplasia and an endometrial stripe of 20 mm or greater, and (2) the same options in all patients with a preoperative diagnosis of endometrial intraepithelial neoplasia. Costs obtained from Centers for Medicare and Medicaid Services and event probabilities and quality of life utility values were obtained through literature review. Results In the case of preoperative endometrial stripe >= 20 mm, hysterectomy with SLN dissection cost $2469 more than hysterectomy with frozen section and gained 0.010 quality adjusted life years, or $44,997/quality-adjusted life years gained. In one-way sensitivity analyses, SLN dissection remained the favored strategy at a willingness to pay threshold of $100,000/quality-adjusted life years unless chronic lower extremity lymphedema after full lymphadenectomy had a likelihood <13.1% (base case value 18.1%); otherwise, SLN dissection was favored with individual variation of all other parameters over plausible ranges. When considering all patients with endometrial intraepithelial neoplasia, hysterectomy with frozen section was favored, with results most sensitive to variation of lymphedema risk after full lymphadenectomy. Conclusion Hysterectomy with SLN dissection in patients with a preoperative endometrial stripe >= 20mm on ultrasound is cost-effective when compared with hysterectomy with frozen section.
引用
收藏
页数:8
相关论文
共 50 条
  • [21] A cost-effectiveness analysis of sentinel lymph node biopsy compared with lymphadenectomy in intermediate- and high-risk endometrial carcinoma
    Trent, Pernille Bjerre
    Eriksson, Ane Gerda
    Staff, Anne Cathrine
    Juul-Hansen, Knut Erling
    Burger, Emily Annika
    Wangen, Knut Reidar
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2024,
  • [22] Sentinel lymph node biopsy at the time of hysterectomy for early-stage cervical cancer: A cost-effectiveness analysis
    Walker, A. R.
    Leite, S.
    Chen, Y. S.
    Huepenbecker, S. P.
    Graul, A.
    GYNECOLOGIC ONCOLOGY, 2025, 195 : 1 - 5
  • [23] Cost-effectiveness analysis of prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer
    Orellana, Taylor
    Bell, Sarah
    Kim, Hayeon
    Rosiello, Abby
    Courtney-Brooks, Madeleine
    Buckanovich, Ronald
    Olawaiye, Alexander
    Sukumvanich, Paniti
    Berger, Jessica
    Lesnock, Jamie
    GYNECOLOGIC ONCOLOGY, 2023, 176 : S257 - S258
  • [24] Prophylactic anticoagulation after minimally invasive hysterectomy for endometrial cancer: a cost-effectiveness analysis
    Bell, Sarah
    Orellana, Taylor
    Garrett, Alison
    Smith, Kenneth
    Kim, Haeyon
    Rosiello, Abigail
    Rush, Shannon
    Berger, Jessica
    Lesnock, Jamie
    INTERNATIONAL JOURNAL OF GYNECOLOGICAL CANCER, 2023, 33 (12) : 1875 - 1881
  • [25] Comparing Single-Site and Multiport Robotic Hysterectomy with Sentinel Lymph Node Mapping for Endometrial Cancer: Surgical Outcomes and Cost Analysis
    Moukarzel, Lea A.
    Sinno, Abdulrahman K.
    Fader, Amanda N.
    Tanner, Edward J.
    JOURNAL OF MINIMALLY INVASIVE GYNECOLOGY, 2017, 24 (06) : 977 - 983
  • [26] Correction: Lymph node evaluation for endometrial hyperplasia: a nationwide analysis of minimally invasive hysterectomy in the ambulatory setting
    Koji Matsuo
    Katharine M. Ciesielski
    Rachel S. Mandelbaum
    Matthew Y. W. Lee
    Neda D. Jooya
    Lynda D. Roman
    Jason D. Wright
    Surgical Endoscopy, 2023, 37 : 6602 - 6602
  • [27] A cost-effectiveness analysis of sentinel lymph node detection in vulvar cancer by preoperative lymphoscintigraphy versus intraoperative detection alone
    Brzezinska, B. N.
    Shepherd, J. P.
    Rath, K.
    Clements, A.
    GYNECOLOGIC ONCOLOGY, 2019, 154 : 198 - 199
  • [28] A cost-effectiveness analysis of sentinel lymph node detection in vulvar cancer by preoperative lymphoscintigraphy versus intraoperative detection alone
    Brzezinska, B. N.
    Shepherd, J. P.
    Rath, K. S.
    Clements, A. E.
    GYNECOLOGIC ONCOLOGY, 2020, 159 (02) : 498 - 502
  • [29] Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis
    H Verry
    S J Lord
    A Martin
    G Gill
    C K Lee
    K Howard
    N Wetzig
    J Simes
    British Journal of Cancer, 2012, 106 : 1045 - 1052
  • [30] Effectiveness and cost-effectiveness of sentinel lymph node biopsy compared with axillary node dissection in patients with early-stage breast cancer: a decision model analysis
    Verry, H.
    Lord, S. J.
    Martin, A.
    Gill, G.
    Lee, C. K.
    Howard, K.
    Wetzig, N.
    Simes, J.
    BRITISH JOURNAL OF CANCER, 2012, 106 (06) : 1045 - 1052